Attorney Amy E. German Joins The Michael Brady Lynch Firm
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. It is my true pleasure to announce that The Michael Brady Lynch Firm has added Amy E. German, Esq., as an associate in our pharmaceutical and medical device practice group. A little background on Amy: Attorney Amy E. German is an
Read MoreActos Manufacturer Agrees to Landmark $2.37 Billion Settlement
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In a huge win for justice and consumer rights, Takeda Pharmaceutical has agreed to pay $2.4 billion to settle thousands of lawsuits from patients and their family members who said that the company’s diabetes drug Actos caused bladder cancer. Takeda, a
Read MoreThe Tragedy of Birth Defects Associated with Zofran During Pregnancy
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In my 18 year career, I have seen a lot of very sad cases of corporate misconduct in the pharmaceutical industry. The case of Zofran is by far one of the saddest. A little background on Zofran: Zofran works by blocking
Read MoreNew FDA Warning on Testosterone Products for Low T is a Game Changer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA just dramatically upped the stakes on the warnings on Low T treatments and the risk of cardiac events. The full FDA communication is below: Testosterone Products: Drug Safety Communication – FDA Cautions About Using Testosterone Products for Low Testosterone
Read MoreActos Bladder Cancer Verdict in Favor of Plaintiff in Philadelphia
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Things are heating up in Actos litigation, with defendant Takeda hit with another verdict rising from the use of the drug the development of bladder cancer. On February 12th, Takeda Pharmaceuticals Inc. was hit with a $2.3 million verdict after a
Read More$2.5m DePuy ASR Hip Verdict in Favor of Plaintiff in Tulsa Trial
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. A recent verdict in favor of the plaintiff reminded Johnson & Johnson that their worries (and financial exposure) over defective ASR hips revised post-settlement are not over. A jury in Tulsa County, Oklahoma on February 3rd returned a $2.5 million compensatory
Read MoreRisperdal Linked to Severe Cases of Gynecomastia in Boys
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. This is truly a sad story of big business at its very worst. The popular drug Risperdal is the focus of mounting filings around the country on behalf of men and boys who allegedly developed gynecomastia, or male breast growth, due
Read More